15.54

4.37% -0.71

After Hours: 15.54

Integra Lifesciences Holdings Corp (IART)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Integra Lifesciences Holdings Corp stock is traded at $15.54, with a volume of 1.33M. It is down -4.37% in the last 24 hours and down -8.96% over the past month. Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Previous Close:

$16.25

Open:

$15.93

24h Volume:

1.33M

Relative Volume:

1.55

Market Cap:

$1.21B

Revenue:

$1.64B

Net Income/Loss:

$-495.80M

P/E Ratio:

-2.4266

EPS:

-6.404

Net Cash Flow:

$-45.25M

1W Performance:

-5.47%

1M Performance:

-8.96%

6M Performance:

+62.72%

1Y Performance:

+0.97%

1-Day Range:

$15.39

$16.04

1-Week Range:

$15.39

$16.78

52-Week Range:

$8.70

$20.49

Integra Lifesciences Holdings Corp Stock (IART) Company Profile

Name

Integra Lifesciences Holdings Corp

Sector

Healthcare (1069)

Industry

Medical Devices (140)

Phone

(609) 275-0500

Address

1100 CAMPUS ROAD, PRINCETON, NJ

Employee

4,427

Twitter

@integra_life

Next Earnings Date

2026-10-29

Latest SEC Filings

IART's Discussions on Twitter

Compare IART vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IART Integra Lifesciences Holdings Corp	15.54	1.26B	1.64B	-495.80M	-45.25M	-6.404
ABT Abbott Laboratories	103.36	182.09B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	91.62	117.54B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	270.01	105.63B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.10	65.16B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.77	49.67B	6.30B	1.07B	1.09B	1.8406

Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-26	Downgrade	Argus	Buy → Hold
Mar-31-25	Upgrade	Argus	Hold → Buy
Dec-02-24	Initiated	Morgan Stanley	Underweight
Oct-07-24	Upgrade	BTIG Research	Sell → Neutral
Jul-30-24	Downgrade	BTIG Research	Neutral → Sell
Jul-30-24	Downgrade	Citigroup	Neutral → Sell
May-07-24	Downgrade	Oppenheimer	Outperform → Perform
May-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-03-24	Upgrade	Citigroup	Sell → Neutral
Dec-05-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Nov-14-23	Initiated	CL King	Buy
Aug-24-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jul-12-23	Upgrade	Jefferies	Hold → Buy
Jun-08-23	Downgrade	Argus	Buy → Hold
May-24-23	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Downgrade	Citigroup	Neutral → Sell
Oct-12-22	Initiated	Jefferies	Hold
Jul-25-22	Initiated	Morgan Stanley	Equal-Weight
Apr-13-22	Downgrade	Truist	Buy → Hold
Dec-17-21	Upgrade	JP Morgan	Underweight → Neutral
Sep-15-21	Downgrade	BTIG Research	Buy → Neutral
Oct-08-20	Downgrade	JP Morgan	Neutral → Underweight
May-27-20	Initiated	Citigroup	Neutral
Apr-03-20	Initiated	SunTrust	Buy
Jan-07-20	Downgrade	Piper Jaffray	Overweight → Neutral
Jan-07-20	Downgrade	Piper Sandler	Overweight → Neutral
Jan-03-19	Initiated	SunTrust	Buy
Nov-28-18	Initiated	UBS	Neutral
Aug-07-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-18	Upgrade	BTIG Research	Neutral → Buy
Jul-02-18	Downgrade	Citigroup	Buy → Neutral
Jan-05-18	Resumed	Cantor Fitzgerald	Neutral
Jan-02-18	Downgrade	BofA/Merrill	Buy → Neutral
Nov-09-17	Reiterated	RBC Capital Mkts	Sector Perform
Oct-30-17	Downgrade	Wells Fargo	Outperform → Market Perform
Oct-27-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-30-17	Initiated	Cantor Fitzgerald	Overweight
May-02-17	Reiterated	RBC Capital Mkts	Sector Perform
Jan-13-17	Reiterated	RBC Capital Mkts	Sector Perform
Jan-06-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Dec-12-16	Initiated	UBS	Buy

View All

Integra Lifesciences Holdings Corp Stock (IART) Latest News

Sep 08, 2026

Integra LifeSciences on Track to Complete FDA Remediation in 2026 - Minichart

Sep 08, 2026

Sep 04, 2026

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference - Yahoo Finance

Sep 04, 2026

Sep 02, 2026

Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis (NASDAQ:IART) - Seeking Alpha

Sep 02, 2026

Aug 22, 2026

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys - TMX Newsfile

Aug 22, 2026

Aug 19, 2026

Is IART Still Attractive as Its Low Valuation Meets Execution Risks? - TradingView

Aug 19, 2026

Aug 14, 2026

Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat

Aug 14, 2026

Integra LifeSciences /US Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com

Aug 14, 2026

Aug 13, 2026

Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control - Stock Titan

Aug 13, 2026

Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.6%Time to Buy? - MarketBeat

Aug 13, 2026

Aug 08, 2026

Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat

Aug 08, 2026

Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart - Yahoo! Finance Canada

Aug 08, 2026

Aug 07, 2026

5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance

Aug 07, 2026

Aug 06, 2026

Integra LifeSciences Holdings Corporation $IART Stock Position Trimmed by Dimensional Fund Advisors LP - MarketBeat

Aug 06, 2026

Aug 05, 2026

IART 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - TMX Newsfile

Aug 05, 2026

Aug 04, 2026

Glenmede Trust Co. NA Raises Stock Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat

Aug 04, 2026

Aug 03, 2026

Healthcare of Ontario Pension Plan Trust Fund Sells 96,400 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat

Aug 03, 2026

Aug 02, 2026

List of 16 Acquisitions by Integra LifeSciences (Aug 2026) - Tracxn

Aug 02, 2026

Aug 01, 2026

integra lifesciences holdings corp Profit Warnings - RTTNews

Aug 01, 2026

Access Investment Management LLC Buys 268,085 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat

Aug 01, 2026

Jul 31, 2026

Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra - Stock Titan

Jul 31, 2026

Jul 30, 2026

Integra LifeSciences Q2 2026 Earnings: Revenue, Financials, and SEC 10-Q Filing Highlights - Minichart

Jul 30, 2026

IART|Integra Lifesciences Holdings Corp|Price:18.245|Chg%:+0.005 - tradingkey.com

Jul 30, 2026

Jul 29, 2026

Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 29, 2026

Is Integra Lifesciences Holdings Corp (IART) Undervalued After Q - GuruFocus

Jul 29, 2026

Integra: Q2 Earnings Snapshot - kare11.com

Jul 29, 2026

Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook - Quiver Quantitative

Jul 29, 2026

Integra LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance Singapore

Jul 29, 2026

Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.

Jul 28, 2026

Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance

Jul 28, 2026

Jul 27, 2026